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Monitoring the action of redox-directed cancer
therapeutics using a human peroxiredoxin-2-based
probe
Troy F. Langford1, Beijing K. Huang2, Joseph B. Lim1, Sun Jin Moon1 & Hadley D. Sikes1
Redox cancer therapeutics target the increased reliance on intracellular antioxidant systems
and enhanced susceptibility to oxidant-induced stress of some cancer cells compared to
normal cells. Many of these therapeutics are thought to perturb intracellular levels of the
oxidant hydrogen peroxide (H2O2), a signaling molecule that modulates a number of different
processes in human cells. However, ﬂuorescent probes for this species remain limited in their
ability to detect the small perturbations induced during successful treatments. We report a
ﬂuorescent sensor based upon human peroxiredoxin-2, which acts as the natural indicator of
small H2O2 ﬂuctuations in human cells. The new probe reveals peroxide-induced oxidation in
human cells below the detection limit of current probes, as well as peroxiredoxin-2 oxidation
caused by two different redox cancer therapeutics in living cells. This capability will be useful
in elucidating the mechanism of current redox-based therapeutics and in developing new
ones.
DOI: 10.1038/s41467-018-05557-y OPEN
1 Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge 02139, USA. 2 Department of
Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge 02139, USA. Correspondence and requests for
materials should be addressed to H.D.S. (email: sikes@mit.edu)
NATURE COMMUNICATIONS |  (2018) 9:3145 | DOI: 10.1038/s41467-018-05557-y | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Hydrogen peroxide (H2O2) can regulate a variety cellularprocesses via the oxidation of speciﬁc cysteine residues ofredox-regulated proteins, which can trigger a range of
cellular responses, including cell growth and proliferation at
lower levels of H2O2, as well as autophagy, apoptosis, and
necrosis at higher levels of this oxidant1–5. Many cancer cells are
thought to have much higher rates of production of H2O2 com-
pared to normal cells due to a combination of both aberrant
metabolism and genetic mutations6,7. As a result of this addi-
tional H2O2 production, many of these cells are thought to have
higher susceptibility to H2O2-induced apoptosis compared to
normal cells8–12. In order to combat this increase in oxidant
production, cancer cells also upregulate key antioxidant species in
order to remove this oxidant from the cell and ensure their
survival6,8. Redox cancer therapeutics target cancer cells’
increased dependence on intracellular antioxidant systems and
enhanced susceptibility to H2O2-induced stress through inhibi-
tion of these antioxidant systems that detoxify the cell, resulting
in elevation of oxidants within the cell8–12. Several small molecule
cancer therapeutics, such as piperlongumine13, are thought to
result in elevated intracellular H2O2 that is central to their toxicity
mechanisms; however, due to the small perturbations produced
in response to several of these drugs, it remains difﬁcult to detect
H2O2 ﬂuctuations in response to these treatments14.
In human cells, cytosolic H2O2 levels are controlled by a
powerful network of speciﬁc reductive reactions primarily
accomplished by peroxiredoxins (Prxs), thioredoxin (Trx), and
thioredoxin reductase (TrxR), with reducing equivalents supplied
by nicotinamide adenine dinucleotide phosphate (NADPH)15,16.
Winterbourn et al.2 noted that human Prxs should scavenge the
majority of H2O2 in human cells on the basis of their second-
order rate coefﬁcients for reaction with H2O2 (on the order of 1 ×
107 M−1s−1)17 and abundance in the cytosol of mammalian cells
(on the order of 1 × 10−4 M)16,18. Further analysis of this pathway
with detailed kinetic models revealed that H2O2 clearance models
that only consider H2O2 consumption by Prxs and neglect all
other antioxidants produce the same clearance curves for all
reasonable levels of H2O2 as those predicted by a full metabolic
model of H2O2 clearance16. One abundant isoform, Prx2,
achieves this high reaction rate via the exceptionally reactive thiol
group of a cysteine residue near the N-terminus of the protein
known as the catalytic cysteine19,20. When the catalytic cysteine is
oxidized to a sulfenic acid, it forms a disulﬁde bond with a second
cysteine residue, known as the resolving cysteine, of an adjacent
Prx2 monomer. This process involves a conformational change
and results in a covalently-linked dimer species. After dimer
formation, Trx reduces the disulﬁde bond between the two Prx2
monomers and regenerates the original proteins, while TrxR
reduces oxidized Trx using electrons from NADPH19,20. This set
of reactions maintains a large amount of reduced Prx2 in the
cytosol of cells16, poised to respond to very small changes in
cytosolic H2O2 ﬂuxes. This feature of the system suggests that
Prx2 oxidation could serve as an indicator for ﬂuctuations in
physiological levels of H2O2, and that human Prx2 fused with one
or more ﬂuorescent proteins could serve as the basis of a speciﬁc
and sensitive sensor for H2O2.
Currently, the most common way to measure H2O2-induced
Prx2 oxidation is through non-reducing gel-electrophoresis fol-
lowed by western blot for Prx2 monomers and dimers21. While
this approach has proven useful in many studies, it requires
laborious gel electrophoresis procedures, pooled cell lysate sam-
ples, and often results in a large amount of variability from
sample to sample. For ultrasensitive H2O2 detection, several
groups have designed genetically-encoded ﬂuorescent probes for
H2O2-induced peroxiredoxin oxidation; this approach has yielded
success in yeast22, where the designed probe was more sensitive
than the current genetically-encoded sensors HyPer and roGFP2-
Orp1, as well as plants23–25, but has not been applied to human
cells, where HyPer and roGFP2-Orp1 are state-of-the-art tools. In
this work, we created a ﬂuorescence resonance energy transfer
(FRET) probe based upon the reactivity of human Prx2 for
ultrasensitive detection of H2O2 in human cells. In order to
maximize the ﬂuorescence change in the two ﬂuorophores upon
dimerization of the reactive domain of the probe, we chose the
ﬂuorescent proteins Clover and mRuby2 as a FRET pair, which
were previously shown to have a higher dynamic range than
conventional cerulean-yellow ﬂuorescent protein FRET pairs and
insensitivity to changes in pH26. In order to validate this new tool,
we puriﬁed the ﬂuorescent probe and quantiﬁed its ﬂuorescent
signal in response to various oxidants and buffers in order to
determine its selectivity and pH sensitivity. Additionally, we
expressed the probe in human epithelial cells and quantiﬁed its
ﬂuorescent signal in response to various perturbations chosen to
assess sensitivity towards H2O2. Following these detailed char-
acterization and validation studies, we were able to detect and
track low levels of H2O2-induced Prx2 oxidation when malignant
cells were treated with the cancer therapeutics auranoﬁn and
piperlongumine. Even though the small elevation of H2O2 in
response to piperlongumine treatment was sufﬁcient to cause
apoptosis14, the H2O2 level was below the lower detection limit of
HyPer, which highlights the unique ability of the probe developed
in this work to detect small, yet relevant, changes in intracellular
H2O2 levels using a responsive domain that is of broad interest in
many biological processes27–29.
Results
Probe responds rapidly and robustly to H2O2. In order to
construct an ultrasensitive H2O2 probe, the genes corresponding
to the three domains of the probe (Clover, Prx2, mRuby2) were
inserted into pcDNA3.1+ via the Gibson assembly method.
Additionally, between each ﬂuorescent protein and the central
Prx2 domain, a short ﬂexible amino acid linker was inserted to
promote proper folding of the ﬂuorescent protein domains
(Fig. 1a). In order to characterize the response of the cytosolic
probe to H2O2, a culture of HeLa cells was transfected with the
gene encoding the probe, exposed to an external bolus addition of
H2O2, and imaged with a wideﬁeld microscope. Upon addition of
H2O2 to the culture, the intensity in the donor ﬂuorescence
channel decreased while the intensity in the donor–acceptor
FRET ﬂuorescence channel increased (Fig. 1b, c). These changes
resulted in a rapid increase in the emission ratio of the probe,
deﬁned as the ratio of intensity in the FRET ﬂuorescence channel
divided by the intensity in the donor ﬂuorescence channel
(Fig. 1d). Upon mutation of both the catalytic and resolving
cysteine residues of the Prx2 domain of the probe to serine,
addition of H2O2 did not elicit a change in the emission ratio,
suggesting that the observed change in the signal of the unmo-
diﬁed probe depends on the activity of one, or both, of these
cysteines (Fig. 1e). In contrast, mutation of only the catalytic
cysteine of the probe followed by addition of H2O2 resulted in a
slight increase in the emission ratio of the probe, but not as large
as the original construct (Supplementary Fig. 1a), which suggests
that disulﬁde bond linkages may also form between probe
molecules and unmodiﬁed, endogenous Prx2 monomers that
result in slight conformational changes in the probe. Interestingly,
mutation of only the resolving cysteine of the probe followed by
addition of H2O2 slightly decreased the emission ratio of the
probe relative to the pre-stimulation value (Supplementary
Fig. 1b), which may reﬂect hyperoxidation of the catalytic
cysteine of the probe from a sulfenic acid to a sulﬁnic or sulfonic
acid30. We present the results of these studies in terms of moles of
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H2O2 per cell as opposed to concentration or total moles of H2O2.
As we and others have previously shown31–34, both the total
moles of H2O2 added as well as the total number of cells present
affect the results obtained from this kind of experiment, whereas
moles of H2O2 per cell is a meaningful metric that may be
compared across studies.
As a complement to intracellular measurements, we puriﬁed
the ﬂuorescent probe in order to assess its speciﬁcity to H2O2 and
sensitivity to environmental factors such as pH. In order to purify
the ﬂuorescent protein, an N-terminal histidine-tagged construct
was expressed in bacteria, and the recombinant protein was
puriﬁed via immobilized metal afﬁnity chromatography (Supple-
mentary Fig. 2). The puriﬁed protein was subjected to various
oxidants to determine the speciﬁcity of the probe (Supplementary
Fig. 3 and Supplementary Fig. 4). Of the oxidants tested, only
H2O2 and tert-butyl hydroperoxide (TBHP) signiﬁcantly
increased the emission ratio of the ﬂuorescent protein, consistent
with previous measurements with ﬂuorescent peroxiredoxin-
based constructs22. In addition to these experiments, the probe
was also subjected to two different treatments to determine the
sensitivity of peroxynitrite; in the ﬁrst experiment, puriﬁed
protein was exposed to the peroxynitrite generator compound
linsidomine (SIN-1), whereas in the second, HeLa cells expressing
the probe were exposed to a solution with nitric oxide, which
diffuses into cells and rapidly reacts with superoxide to form
peroxynitrite (Supplementary Fig. 5 and Supplementary Fig. 6).
In both instances, the signal from the probe did not increase
signiﬁcantly after the treatment, once again consistent with
previous measurements with analogous constructs22. In a
separate set of experiments, we also tested the robustness of the
puriﬁed probe to buffers with different pHs (Supplementary
Fig. 7). The results of this study indicate that the emission ratio of
the both of the reduced and oxidized probe remain relatively
constant within the pH range of 6.6 to 7.8.
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Fig. 1 Design and function of human Prx2-based FRET probe. a Schematic representation of Prx2 based probe. b Response of cytosolic sensor upon
oxidation by H2O2. Changes in each of the two ﬂuorescent channels upon stimulation with H2O2 suggest that the fusion protein adopts a conformation in
which the two ﬂuorophores are in closer proximity in the oxidized state. Pseudo-coloring of one HeLa cell is shown for illustrative purposes. c Normalized
emission from the donor and FRET ﬂuorescent channels over time upon stimulation with approximately 60 × 10−15 mol per cell in HeLa cells expressing the
functional Prx2 probe. d 625/525 nm emission ratio over time in HeLa cells expressing the functional Prx2 probe upon stimulation with a control bolus
(culture medium only, blue line) or stimulation with approximately 60 × 10−15 mol H2O2 per cell (black line). e 625/525 nm emission ratio over time in
HeLa cells expressing Prx2-based probe with both the Prx2 catalytic cysteine residue and resolving cysteine residue mutated to serine upon stimulation
with a control bolus (culture medium only, blue line) or stimulation with approximately 60 × 10−15 mol H2O2 per cell (black line). 2 mL of 20 μM H2O2 was
added to 7 × 105 adherent cells to achieve 60 × 10−15 mol H2O2 per cell. Data points represent mean emission ratio ± S.E.M. for nine cells and are reﬂective
of three biological replicates
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Probe responds to low levels of extracellular H2O2. We further
assessed the dynamics of probe oxidation and reduction with
several additional H2O2 bolus perturbations. We ﬁrst determined
the amount of H2O2 required to completely saturate the probe
(Fig. 2a), and then titrated down with lower quantities of H2O2 in
order to study the dynamic behavior of the system (Fig. 2b-g,
Supplementary Fig. 8). In order to test whether the probe
responded to successive additions of H2O2, we also stimulated
cells expressing the probe with a H2O2 bolus equivalent to that in
Fig. 2c, waited until the emission ratio returned to the baseline
level, and added a second H2O2 bolus of the same amount
(Supplementary Fig. 9). In addition, in order to determine how
long the probe signal persisted in the cell after saturation of the
probe, we stimulated cells expressing the probe with a H2O2 bolus
equivalent to that in Fig. 2a and waited until the emission ratio
returned to the baseline level (Supplementary Fig. 10). Lastly, in
order to determine the minimum and maximum fold changes for
the cytosolic probe, cells with the probe were exposed to the thiol
oxidant diamide and the disulﬁde reductase dithiothreitol, and
the ﬁnal fold change of the probe signal over the 10-min mea-
surement period was calculated (Supplementary Fig. 11). As
expected, maximum fold change achieved with diamide was
higher than that achieved with H2O2 bolus addition, as diamide
likely oxidizes intracellular reductases such as Trx and thus
prevents the reduction of oxidized Prx protein. Additionally, the
sensor fold change did not change upon addition of dithiothreitol
to the cell culture, which suggests that the probe exists almost
entirely in the reduced form at basal levels of intracellular H2O2.
This ﬁnding agrees well with results from kinetic models of this
system, which predict that approximately 99.8% of Prx2 resides in
the reduced state at basal H2O2 concentrations16.
To examine whether cytosolic expression of the probe perturbs
the native, H2O2-clearing activity of endogenous Prx2, we
stimulated cells with and without the ﬂuorescent probe with
various amounts of external H2O2, subjected the lysates from
these cells to non-reducing, denaturing gel electrophoresis (i.e.,
non-reducing SDS-PAGE) followed by immunoblots for Prx2,
and quantiﬁed the fraction of dimerized Prx2 in each sample
(Fig. 3a–c). These membranes were also blotted for hyperoxidized
Prx in order to ensure that no hyperoxidized species formed
during these experiments (Supplementary Fig. 12). In lysates
from these cells, two clear protein bands appeared that
corresponded to reduced Prx2 monomers (21 kDa) and oxidized
dimers (42 kDa) in the cytosol. Comparison of Fig. 3a with 3b
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Fig. 2 Concentration-dependent kinetics and magnitude of the ﬂuorescent response to stimulation with H2O2. a–e 625/525 nm emission ratio as a function
of time in HeLa cells expressing the Prx2-based probe upon stimulation with approximately 60 × 10−15 mol H2O2 per cell (a), 30 × 10−15 mol H2O2 per cell
(b), 15 × 10−15 mol H2O2 per cell (c), 3 × 10−15 mol H2O2 per cell (d), and 0 × 10−15 mol H2O2 per cell (e). Mol per cell values correspond to 2mL of 20, 10,
5, 1, or 0 μM H2O2 added extracellularly to 7 × 105 adherent cells. f Normalized peak fold-change of the probe’s signal upon stimulation with different
amounts of H2O2. Bar graph plus dot plot shown in Supplementary Fig. 23. Data points represent mean ratio ± S.E.M. for 18 cells from two biological
replicates. g Probe ratio over time in several HeLa cells upon stimulation with the same amount of H2O2 as in part (c). Numbers next to the color scale
represent raw emission ratios and the time points indicate time since start of image acquisition. H2O2 was added 2.5 min after the start of image
acquisition. Dashed white lines represent boundary of each image
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indicates that expression of the probe does not shift the onset of
native Prx2 dimerization.
More detailed examination of these redox western blots,
provided in full as Supplementary Fig. 13, revealed several higher-
molecular weight protein bands that likely correspond to the
reduced probe monomers (75 kDa), oxidized heterodimers
between probe and Prx2 monomers (100 kDa) and oxidized
homodimers between two identical probe molecules (150 kDa). In
order to observe the native state of the probe, lysates from cells
expressing the probe were subjected to blue-native gel electro-
phoresis (BN-PAGE) and immunoblotted for both Prx2 and
green ﬂuorescent protein (Supplementary Fig. 14). No bands
greater than 150 kDa were detected in the native blots, which
suggests that the probe molecules do not assemble into high-
molecular weight oligomers in these cells under the conditions
used in our experiments.
Probe responds to low levels of intracellular H2O2. To progress
beyond convenient, yet unrealistic, bolus additions of H2O2 we
used the enzyme D-amino acid oxidase (DAAO), which has been
previously used to produce continuous, tunable amounts of H2O2
within mammalian cells35–37. We expressed this enzyme in HeLa
cells that contained either the Prx2-based probe or HyPer, a
genetically-encoded H2O2 probed based upon the bacterial
transcription factor OxyR, which is known to react with H2O2
with a second order rate constant nearly two orders of magnitude
slower than Prx238. Upon expression of DAAO in cell lines with
the ﬂuorescent probes, we supplied cells with various amounts of
D-alanine, a substrate of DAAO, which resulted in steady pro-
duction of H2O2 over a 4.5-h time period (Fig. 4a and Supple-
mentary Fig. 15). We then measured the ﬂuorescent signal from
the two probes in each cell line over the same time period, and
compared the initial signal with the ﬁnal signal for each con-
centration of D-alanine (Fig. 4b, c and Supplementary Fig. 16). In
these experiments, the signal from the Prx2-based probe
increased signiﬁcantly compared to baseline value even at the
lowest concentration of D-alanine concentrations, whereas the
HyPer signal did not increase signiﬁcantly compared to the
baseline value at D-alanine concentrations below 25 mM. In
addition to this result, we observed that the signal from the Prx2-
based probe appeared to saturate at D-alanine concentrations
above 15 mM, whereas the HyPer signal gradually increased as
the D-alanine concentration increased. Together, these results
suggest that the Prx2-based probe responds to lower intracellular
amounts of H2O2 compared to HyPer.
Probe responds to decreases in TrxR activity. We next sought to
determine the sensitivity of the Prx2-based probe to changes in
Trx/TrxR activity. Since endogenous Prx2 utilizes the Trx/TrxR
system for reduction of oxidized protein, we hypothesized that
the Trx/TrxR system would also reduce probe molecules, and that
inhibition of this reduction machinery would result in rapid
accumulation of oxidized probe molecules coupled with an
increased emission ratio from the probe. In order to test this
hypothesis, we treated cells expressing either the Prx2-based
probe or HyPer with the known TrxR inhibitor and cancer
therapeutic compound auranoﬁn8,11, which has been previously
shown to cause the accumulation of oxidized Prx2 dimers in
human cells21 (Fig. 5a). Since HyPer primarily utilizes glutar-
edoxin for reduction of oxidized protein39, we expected that this
probe would be less sensitive to auranoﬁn induced perturbations,
and would only respond after signiﬁcant accumulation of oxi-
dized Prx2, which would allow HyPer to compete more effectively
for intracellular H2O2. As expected, when HeLa cells were treated
with auranoﬁn, the activity of TrxR in the lysate decreased in a
dose-dependent manner (Fig. 5b and Supplementary Fig. 18).
Concomitant with this decrease in TrxR activity, the signal from
the Prx2-based probe increased signiﬁcantly compared to the
baseline value at inhibitor concentrations above 1 μM, and
quickly saturated at higher concentrations (Fig. 5c). In contrast,
the HyPer signal only increased signiﬁcantly from the baseline
value at concentrations at or above 16 μM, and continued to
increase as the inhibitor concentration increased (Fig. 5d). This
change also corresponded to an increase in the intensity of Prx2
dimers as well as probe-based dimers, which started to accumu-
late on western blots at inhibitor concentrations above 8 μM
(Supplementary Fig. 19). Together, these observations suggest
that the Prx2-based probe rapidly responds to changes in the
activity of the Trx/TrxR system, and support the hypothesis that
HyPer, which primarily utilizes glutaredoxin for reduction, only
responds signiﬁcantly to the treatment after accumulation of
oxidized Prx2 occurs.
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Probe responds to therapeutic-induced H2O2 elevation. In our
last set of experiments, we asked if we could use the Prx2-based
probe to detect redox perturbations associated with the redox
therapeutic piperlongumine13. Recently, Huang et al.14. demon-
strated that treatment of human epithelial cells with 10 μM
piperlongumine results in the elevation of oxidized Prx2 dimers
in addition to irreversible S-glutathionylation of proteins and cell
death14. The authors of this study also showed that upon over-
expression of catalase in the cytosol of these cells, piperlongumine
treatment resulted in signiﬁcantly less oxidized Prx2 in addition
to lower cytotoxicity, which suggests that elevation of cytosolic
H2O2 is central to the toxicity of piperlongumine. In order to
assay for increased intracellular H2O2 after the addition of
piperlongumine, we incubated a culture of HeLa cells with the
drug for a period of 10 h and immuno-blotted the lysates for
Prx2. Treatment of these cells with a dose of piperlongumine that
was shown in past work13 to selectively kill several kinds of cancer
cells caused an observable increase in the level of Prx2 dimer-
ization compared to the control case (Fig. 6a). We next stably
expressed the Prx2-based probe in the cytosol of HeLa cells and
recorded the emission ratio of the sensor in the cells at various
points in time after addition of piperlongumine (Fig. 6b). Upon
addition of the drug to the cell culture media, the emission ratio
of the probe began to increase after approximately 4–6 h, and
steadily increased for the remainder of the 10-h incubation period
(Fig. 6c, d). This signal was also reversible upon introduction of
additional catalase in the cytosol (Supplementary Fig. 20). We
then stably expressed the Prx2-based probe in the cytosol of A549
cells, which are known to overexpress certain antioxidant proteins
as a result of hyperactive nuclear factor erythroid 2-related factor
2 (Nrf2)40,41, and repeated the previous experiment. As expected,
upon stimulation with the drug, the signal from the probe did not
increase, suggesting a lower cytosolic H2O2 concentration in
response to the drug (Fig. 6e, f). In our last set of experiments, we
stably expressed the H2O2 probe HyPer in the cytoplasm of HeLa
cells and performed the piperlongumine experiment one more
time. Upon stimulation with the drug, the HyPer emission ratio
did not signiﬁcantly change from the control case over the 10-h
incubation period (Fig. 6g, h). These results agree with the results
obtained by Huang et al.14, and suggest that the cytoplasmic
H2O2 ﬂux required for this Prx2 oxidation is below the detection
limit of HyPer.
Discussion
Due to the variety of roles that different oxidants play in both
healthy and diseased cells, there is signiﬁcant interest in the
development of new ﬂuorescent probes that can isolate the effects
of therapeutic agents that perturb these species. Synthetic small
molecule ﬂuorescent probes for H2O2 have been developed, but
many of these probes lack speciﬁcity and/or sensitivity for
H2O242–45. Similarly, several protein-based ﬂuorescent probes
that utilize the H2O2-sensitive protein domains of OxyR and
Orp1 have been reported and have been successfully applied to
study the effects of several H2O2-mediated processes in human
cells38,39. Because Prxs react with H2O2 much more rapidly than
these probes, some processes that only slightly elevate H2O2 may
require a more highly reactive probe38. Recently, Morgan et al.22.
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designed a ﬂuorescent probe based upon the redox relay between
the yeast peroxiredoxin Tsa2 and the ﬂuorophore roGFP2 and
applied it in yeast, where it was more sensitive than other probes
based on less reactive peroxidase domains22. In this study, we
designed a probe based on human Prx2, the dominant peroxir-
edoxin species in human cells; this design allowed us to accurately
track small increases in intracellular H2O2 that could not be
detected using state-of-the art genetically-encoded probes.
Based on our choice of Prx2 as the reactive domain of the
probe, we expected that the ﬂuorescent probe would react with a
similar speciﬁcity towards H2O2 and in a similar responsive range
as the endogenous protein. Indeed, our experiments with the
puriﬁed probe protein suggest that the probe has very high
selectivity for H2O2 over other oxidants, with the exception of
TBHP, which also oxidizes endogenous Prxs. In agreement with
previous measurements from peroxiredoxin-based probes, TBHP
caused an increase in the signal from our probe, but the other
oxidants tested did not. The emerging literature related to
ferroptosis46,47 has drawn new attention to the intersection of
iron homeostasis and dysregulation with intracellular levels of
various peroxides. Use of the Prx probe we report to study
alterations in iron homeostasis will warrant additional validation
experiments to understand whether and how such differences
inﬂuence the signal from the probe.
Our experiments with different pH buffers suggest that the Prx
FRET probe has better pH stability than HyPer, as a result of the
choice of ﬂuorophores rather than the choice of H2O2 reactive
domains. As originally reported, HyPer’s excitation ratio (500
nm/420 nm) in the reduced form at pH 7.4 is greater than its
excitation ratio in the fully oxidized form at pH 7.2, and pH
controls are always necessary. Supplementary Fig. 7 shows that
the Prx probe’s emission ratios in the reduced form are always
less than the emission ratios exhibited by the oxidized form. The
magnitude of the error bars in Supplementary Fig. 7 demonstrate
that pH controls should only be necessary in the subset of
experiments that show small FRET increases comparable with
variability in the values for the reduced probe as a function of pH.
Our measurements from the cytosolic probe upon stimulation
with different amounts of H2O2 indicate that the ﬂuorescent
Prx2-based probe has a responsive range similar to that of the
native, unmodiﬁed protein. Reactivity with H2O2 does not appear
to be altered by fusion with two ﬂuorescent protein domains.
Moreover, the relatively low cell-to-cell variability of the probe’s
signal (approximately 5% of the maximum fold change in these
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experiments) allowed us to visualize very small differences in
external H2O2. Based on bolus addition experiments, the probe
reached saturation upon exposure to approximately 30 fmol H2O2
per cell. Given that peroxiredoxin does not become hyperox-
idized21 at this concentration (Supplementary Fig. 12) the gra-
dient of H2O2 across the plasma membrane of HeLa cells is
approximately 650-fold48, and this extracellular concentration
corresponds to an intracellular concentration of approximately
15 nM. If the H2O2 perturbation in a process of interest is
extreme enough that signiﬁcant hyperoxidation or saturation of
oxidized Prx2 would result, an ultrasensitive probe such as the
one we report here would not be needed, and other H2O2 probes,
such as HyPer or roGFP2-Orp1, may serve as the better choice.
We advocate experiments using complementary techniques such
as immunoblots with antibodies speciﬁc to hyperoxidized Prx in
cases where extreme intracellular levels of H2O2 are suspected, or
to rule these out.
Similar to other genetically-encoded ﬂuorescent probes for
H2O2, we observed a slight shift in the ﬂuorescence ratio of the
probe before addition of any oxidant in experiments occurring on
the minutes-timescale where samples were imaged frequently. In
Fig. 2 and in Supplementary Figures 9 and 10, a slight upward
drift of the emission ratio is apparent. Examination of the data
used to calculate emission ratios shows that the upward drift is a
true FRET signal rather than a ratio change attributable to pho-
tobleaching. This monotonic upward drift was not observed in
experiments that occurred on the hours-timescale with less fre-
quent imaging (Fig. 6, Supplementary Figure 16). In order to aid
in interpretation of data in all of these experiments, we recom-
mend the use of control experiments in which media without any
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stimulant is added to cells so that changes in the emission ratio of
the cells after addition of the stimulant can be compared with the
baseline signal over the same period of time.
Given that the concentration of endogenous Prxs is on the
order of 1 × 10−4 M16,18, and that the typical concentration of
ﬂuorescent protein constructs is on the order of 1 × 10−6 M49, we
hypothesized that the presence of the probe would not sig-
niﬁcantly affect the level of oxidized Prx2 in the cytosol upon
stimulation with H2O2. As expected, the concentration of the
intracellular probe was determined to be approximately 1 × 10−6
M (Supplementary Fig. 21), and expression of the probe in the
cytosol did not signiﬁcantly affect the observed amount of oxi-
dized endogenous Prx2 dimers upon treatment with H2O2,
although we anticipate that much higher expression levels of the
probe may impact the activity of the endogenous protein. Cur-
rently, it is not known whether recombinant peroxiredoxin
constructs assemble into high-molecular weight oligomers upon
expression in mammalian cells50 in a similar fashion to analogous
probes in yeast22. While we did see evidence of high molecular
weight oligomers of endogenous Prx2 in our native gel electro-
phoresis experiments in samples probed with an antibody speciﬁc
to human Prx2 (in agreement with previous studies conducted
with lysates from mammalian cells51,52), we did not see any
signiﬁcant formation of high molecular weight oligomers in
samples probed with antibody against GFP, which suggests that
the probe does not form these oligomeric complexes under the
conditions we used and does not require them to function in
these cells.
The probe developed in this work was also characterized in
terms of sensitivity towards intracellular H2O2 generation. Most
current genetically-encoded H2O2 sensors (e.g., HyPer and
roGFP2-Orp1) are based on protein domains that react with
H2O2 with a relatively low rate coefﬁcient (on the order of 1 ×
105 M−1s−1)38. In contrast, Prx2 reacts with H2O2 with a rate
coefﬁcient nearly two orders of magnitude higher (on the order of
1 × 107 M−1s−1)17. In combination with the abundance of Prx2 in
the cytosol of human cells (on the order of 1 × 10−4M)16,18 and
reduction by Trx, Prx2 kinetically outcompetes other potential
reaction partners for H2O2 in the cell, which allows it to respond
to very small ﬂuctuations in the H2O2 level before other proteins
that contain less reactive cysteines can react with H2O2. In our
experiments with the cytosolic H2O2 generator DAAO, cells
expressing the Prx2-based probe responded to lower amounts of
the D-alanine compared to cells expressing HyPer over the
timescale of hours (Supplementary Fig. 16) as well as immediately
after D-alanine addition (Supplementary Fig. 17). We observed
that higher concentrations of D-alanine were required to induce
changes in HyPer’s ratiometric signal in comparison with a
previous study37. This difference may result from differences in
the expression levels of DAAO or HyPer or both; each are
expected to impact the results37,49. In order to control for
variability expected as a function of DAAO’s expression level, we
transfected cell lines with equal amounts of DAAO in order to
compare the two ﬂuorescent probes. Our results from this
experiment suggest that Prx2-based probe responds to lower
levels of intracellular H2O2 than HyPer, and based on the results
obtained from Morgan et al.22., we expect that this probe would
also out-compete other genetically-encoded probes for H2O2 with
similar reactivity as HyPer.
After detailed characterization of the probe’s reactivity with
H2O2, we used it to detect perturbations caused by redox cancer
therapeutics. Recently, several studies have suggested that Prxs
may serve as the focal point for many redox-based stress response
pathways due to their ability to not only rapidly clear H2O2 from
the cytosol, but also to directly affect the activity of other redox-
regulated proteins in the cytosol through disulﬁde exchange
mechanisms53,54. Cells utilize reductase enzymes such as Trx and
TrxR to maintain a large pool of reduced Prxs in the cytoplasm
which can respond to small ﬂuctuations in H2O2. One way redox
cancer therapeutics are thought to perturb this Prx/Trx/TrxR
pathway in cancer cells is through inhibition of the reduction
pathways that cells used to regenerate reduced antioxidant
enzymes, which results in accumulation of oxidized peroxir-
edoxin species that can participate in signaling reactions9,11. In
our experiments with the TrxR inhibitor auranoﬁn, we treated
cancer cells with an amount of inhibitor sufﬁcient to cause near-
complete inhibition of TrxR activity and observed a signiﬁcant
increase in the emission ratio of our probe. Other redox ther-
apeutics also cause an increase in the intracellular level of H2O2
that results in selective toxicity to a wide variety of tumors12. In
our experiments with the compound piperlongumine, we treated
cancer cells with an amount of drug previously shown to induce
elevation of cytosolic H2O2 that was essential to toxicity over a 48
h period14 and observed a signiﬁcant increase the emission ratio
of our probe, which was reversible upon over-expression of cat-
alase in the cytosol. In both of the above examples, we were
unable to see any change in the emission ratio from HyPer, which
suggests that the probe developed in this work has the capability
to sense these slight, but physiologically-relevant, redox
therapeutic-induced perturbations.
In conclusion, we created and characterized an ultrasensitive
genetically-encoded probe for H2O2 based on human Prx2. We
used this probe to track changes in TrxR activity as well as
intracellular H2O2 generation in response to the cancer ther-
apeutics auranoﬁn and piperlongumine, respectively. We also
compared the signal of this probe to that of another commonly
used probe in the ﬁeld, which was unable to detect the slight
perturbations associated with these treatments. We believe that
these capabilities highlight the potential of this probe as a valuable
tool for the measurement of H2O2-mediated processes in human
cells, and uniquely position it to offer insight into the mechanism
of action a number of different therapeutic compounds in which
elevation of oxidative species is thought to play a role8,9,11,55.
Methods
Reagents. All reagents were obtained from Sigma-Aldrich unless otherwise
speciﬁed.
Construction of ﬂuorescent probe. The cloning sequences for Clover, mRuby2,
and Prx2 were isolated from their original plasmids via polymerase chain reaction
(PCR). pcDNA3.1-Clover-mRuby2 was a gift from Kurt Beam (Addgene plasmid #
49089); pQTEV- PRDX2 was a gift from Konrad Buessow (Addgene plasmid #
31338). Next, splice overlap extension PCR reactions were used to add 30-40
nucleotide sequences to the 3’ of the Clover gene and the 5’ end of the mRuby2
gene. These oligonucleotides contained the sequences for the linker sequences
between the ﬂuorescent protein and Prx2 domain and also an overlap region
between the ﬂuorophore and the Prx2 domain for the Gibson assembly reaction.
Next, a second round of splice overlap extension PCR reactions were used to add
vector overlap sequences to the 5’ end of the Clover gene and the 3’ end of the
mRuby2 gene. In order to create the ﬁnal fusion product, the three gene fragments
were assembled into a linearized vector via Gibson assembly. In order to obtain the
linearized vector for the Gibson assembly reaction, the pcDNA3.1(+) mammalian
expression vector (ThermoFisher Scientiﬁc) was digested with EcoRI/XhoI (New
England Biolabs) for 15 min at 37 °C. The three gene fragments were then co-
incubated with the linearized vector and Gibson assembly master mix (New
England Biolabs) at 60 °C for 60 min.
Cell culture and stable cytosolic expression of probe. Hela cells (ATCC® CCL-
2) and HEK-293 cells (ATCC® CRL-1573) lines were cultured in Dulbecco’s
Modiﬁed Essential Medium (DMEM; Lonza) with 10% Fetal Bovine Serum (FBS;
ATCC) at 37 °C, 95% air and 5% CO2. Cell lines obtained directly from ATCC were
not authenticated or tested for mycoplasma. Media in the culture dish was replaced
with fresh media every 2–3 days, and the cells were passaged every 4–5 days. In
order to create a cell line with stable expression of the fusion construct, the
ﬂuorescent protein was constitutively expressed under control of the human
cytomegalovirus (CMV) promoter with the pLJM1 lentiviral vector; the original
plasmid, pLJM1-EGFP, was a gift from David Sabatini (Addgene plasmid # 19319).
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A HEK 293FT cell culture was ﬁrst transfected with the plasmid of interest along
with lipofectamine 2000 (Invitrogen) in Opti-MEM media (ThermoFisher Scien-
tiﬁc) via the manufacturer’s instructions. 24 h after transfection, the media in the
HEK culture was replaced with DMEM supplemented with 10% FBS; after an
additional 24 h of incubation, the media in the HEK culture was collected and the
supernatant containing the lentiviral particles was isolated. The lentiviral particles
were added to a separate HeLa cell culture along with 6 μg/mL polybrene and the
cells were incubated for approximately 72 h. The HeLa cell were then removed
from the dish with 0.25% Trypsin-EDTA (ThermoFisher Scientiﬁc) and re-plated
onto a 10 cm dish with 8 mL of DMEM supplemented with 10% FBS and 6 μg mL
−1 puromycin. Cells were grown in this selective media for a period of 4-5 days
before the cell stocks were prepared.
Characterization of probe reactivity in human cells. Prior to the experiment,
either 1.75 × 105 cells or 3.5 × 105 cells were seeded into a single well of a 6-well
plate (Corning) with approximately 9.5 cm2 of available growth area. After either
24 h or 48 h of incubation, respectively, cells were transiently transfected with 1.5
μg of the plasmid of interest with Lipofectamine 2000 according to the manu-
facturer’s instructions. After 24 h of incubation, cells were washed once with 1 mL
of phosphate buffered saline (PBS) (1×) and then placed in 1 mL of Roswell Park
Memorial Institute (RPMI) 1640 media with no phenol red (ThermoFisher Sci-
entiﬁc). For each data set, baseline signal was acquired for 2.5 min; once 2.5 min
had elapsed, 1 mL of RPMI 1640 medium with 40 μM H2O2 was added to the cells
in each well to reach a ﬁnal concentration of 20 μMH2O2 in a total volume of 2 mL
a ﬁnal cell density of 3.5 × 108 cells L−1. Approximate values for mols H2O2 per cell
were calculated by dividing the concentration of H2O2 (in units of mols L−1) by the
cell density (expressed in cells L−1).
Characterization of cytosolic probe dose response to H2O2. Prior to the
experiment, either 1.75 × 105 cells or 3.5 × 105 cells stably expressing the ﬂuor-
escent Prx2 probe were seeded onto each well of a 6-well plate with approximately
9.5 cm2 of available growth area. The day of the experiment, cells were washed with
1 mL of PBS (1×) and then placed in 1 mL of RPMI 1640 media with no phenol
red. For each data set, baseline signal was acquired for 2.5 min. After 2.5 min had
elapsed, 1 mL of RPMI 1640 medium with an H2O2 concentration of 40, 20, 10, 2,
or 0 μM H2O2 was added to the cell culture to reach ﬁnal H2O2 concentrations of
20, 10, 5, 1, and 0 μMH2O2, in a total volume of 2 mL along with a ﬁnal cell density
of 3.5 × 108 cells L−1. Fluorescent images were acquired in the same manner as
described as above. As before, approximate values for the mol H2O2 per cell were
calculated by dividing the concentration of H2O2 (in units of mol L−1) by the cell
density (expressed in cells L−1).
Production of intracellular H2O2 from D-amino acid oxidase (DAAO). In order
to continuously produce H2O2 in the cytosol of HeLa cells, DAAO, which we
previously14 cloned into the pLJM1-EGFP construct (Addgene plasmid # 19319),
was stably expressed under control of the CMV promoter in the cytosol of HeLa
cells containing either the Prx2-based probe or HyPer with the procedure described
above. Cells were grown in the selective media for a period of 2 days before the cells
were passaged again. The day before the experiment, 3.5 × 105 cells were seeded
onto the surface of a 6-well plate. The day of the experiment, cells were washed
once with PBS (1×) and supplemented with 1 mL of RPMI 1640 (1×) containing 5
μM ﬂavin adenine dinucleotide (FAD). Before addition of D-alanine (the DAAO
substrate) to the wells, images in each ﬂuorescent channel were acquired for each
well. After these images were acquired, D-alanine (dissolved in RPMI 1640) was
added to the wells to reach ﬁnal D-alanine concentrations of 50, 25, 15, and 7.5
mM in a total volume 2mL; as a control, an equivalent volume of RPMI 1640 with
no D-alanine was added to a separate cell sample. Images were acquired in each
ﬂuorescent channel in each well after 1, 2, and 4.5 h.
Treatment with auranoﬁn and piperlongumine. For experiments that involved
the TrxR inhibitor auranoﬁn (Cayman Chemical Company), solid auranoﬁn was
dissolved in sterile-ﬁltered DMSO to make a 32 mM stock solution the day of the
experiment. The auranoﬁn stock solution was then added to culture medium
comprised of DMEM supplemented with 10% FBS to reach ﬁnal auranoﬁn con-
centrations of 32, 16, 8, 4, and 1 μM in a total volume of 2 mL culture medium.
Pure dimethyl sulfoxide (DMSO) was used as a control. Cells were then incubated
at 37 °C for a period of 90 min. After incubation, the signal in each ﬂuorescent
channel was acquired in three different regions of each well. For experiments that
involved the cancer therapeutic piperlongumine, solid piperlongumine (Cayman
Chemical Company) was dissolved in DMSO to make 30 mM stock solution the
day of the experiment. Before addition of the piperlongumine to the cell culture,
images in each ﬂuorescent channel were acquired for each well. After these images
were acquired, the piperlongumine stock solution was then added to the media to
reach a ﬁnal piperlongumine concentration of 10 μM in a total volume 2.5 mL; as a
control, an equivalent volume of DMSO was added to a separate cell sample.
Images were acquired in each ﬂuorescent channel in each well every 2 h for a
period of 10 h.
Selenocystine assay for TrxR activity. Immediately after treatment with aur-
anoﬁn, cells were washed twice with PBS (1×) on ice then treated with 100 µL of 1%
Triton x-100 supplemented with 1x HALT protease cocktail (ThermoFisher Sci-
entiﬁc) to lyse the cells. The lysed cells were then re-pelleted at 12,000 g for 10 min.
The supernatant of the solutions was then collected and the protein content in the
solution was assessed via the bicinchoninic acid (BCA) assay. 40 μg of protein were
then added to a solution containing 400 μM NADPH (VWR) and 800 μM sele-
nocystine (ThermoFisher Scientiﬁc). The absorbance of the solution at 340 nm was
then measured every 2 min for a period of 90 min.
Gel electrophoresis and peroxiredoxin-2 western blots. For each experiment in
which western blots were used, the adherent cells were ﬁrst washed twice with PBS
(1×). For experiments in which H2O2 was used, the liquid in each well was replaced
with 1 mL of PBS and the H2O2 was added to the wells in the same manner as
above. After approximately 30 s, the liquid in each well was aspirated and replaced
with 2 mL of 100 mM methyl methanethiolsulfonate (MMTS) in order to block any
free thiol groups as described previously. The plates were then incubated on ice for
a period of 20-30 min, and washed twice with 1 mL PBS. Next, 100 µL of 1% Triton
x-100 supplemented with 1x HALT protease cocktail was added to lyse the cells.
The lysed cells were then re-pelleted at 12,000 g for 10 min. The supernatant of the
solutions was then collected and the protein content in the solution was assessed
via the BCA assay. 25 μg of protein was then loading into a tris-tricine acrylamide
gel and subjected to SDS-PAGE under non-reducing conditions (i.e. with no β-
mercaptoethanol in sample buffer). After the separated lysates were transferred to a
PVDF membrane (Bio-Rad) (1 h at 100V), the blot was blocked and incubated with
either goat primary antibody for Prx2 (R&D Systems, Catalog # AF3489) (at a
dilution of 1:800) or goat primary antibody for GFP (R&D Systems, Catalog #
AF4240) at 4 °C overnight and then with donkey anti-goat IR 688 (Licor) (at a
dilution of 1:10,000) for 1 h at approximately 22 °C. The tagged proteins were then
visualized on the Odyssey CLx Infrared Imaging System. GAPDH was used as a
loading control for all blots. Uncropped version of all blots in main text shown in
Supplementary Figure 22.
Fluorescent measurements and image analysis. Adherent cells were imaged
with an inverted Olympus IX81 wideﬁeld microscope with an Olympus plan
ﬂuorite 10x dry objective (NA= 0.30). A 200W metal-arc lamp (Prior) was used as
a power source. For ratiometric FRET measurements, two different ﬁlter sets were
used: for Clover ﬂuorescence measurements, a 488/6 nm excitation ﬁlter (Semrock)
was used with a 525/40 nm emission ﬁlter (Semrock); for Clover-mRuby2 FRET
ﬂuorescence measurements, a 488/6 nm excitation ﬁlter was used with a 625/40 nm
emission ﬁlter (Semrock). A 1000 ms exposure time at 25% lamp intensity was used
to acquire images in both ﬂuorescent channels. For image analysis, 16-bit.tif images
were exported to ImageJ and regions-of-interest (ROIs) were then drawn around
cells to be analyzed. In order to calculate the raw emission ratio in each ROI at each
time point, the background-subtracted FRET ﬂuorescence intensity was divided by
the background-subtracted Clover ﬂuorescence intensity in ImageJ.
For experiments in which the ﬂuorescent probe HyPer was used, the following
two ﬁlter sets were used: for short wavelength HyPer excitation, a 415/6 nm
excitation ﬁlter (Semrock) with a 525/40 nm emission ﬁlter (Semrock); for long
wavelength HyPer excitation, a 488/6 nm excitation ﬁlter with a 525/40 nm
emission ﬁlter (Semrock). A 250 ms exposure time at 10% lamp intensity was used
to acquire the images in both channels. ROIs were determined in images from both
ﬂuorescent channels as above. In order to calculate the ratiometric HyPer signal
(i.e., the HyPer ratio) in each ROI at each time point, the background-subtracted
ﬂuorescence intensity from the 488 nm excitation channel was divided by the
background-subtracted ﬂuorescence intensity from the 415 nm excitation channel
in ImageJ.
For all images, background-subtraction was performed in ImageJ with the
rolling ball algorithm. In order to create the emission ratio image, the background-
subtracted 16-bit.tif images for each ﬂuorescent channel were imported into
MATLAB and divided pixel-by-pixel.
Statistical analysis. All experimental emission ratio values are reported as the
mean value ± S.E.M. In order to calculate the mean raw emission ratio value for
each sample, the raw emission ratio was calculated for the designated number of
cells from the background-subtracted images for each timepoint; these values were
then averaged to obtain the raw emission ratio values for these cells. Neither the
brightest cells nor the dimmest cells were used for probe characterization. Probe
fold change values are reported as mean value ± S.E.M.; mean probe fold change
values were determined in a similar manner to the raw emission ratios. The nor-
malized fold change values were determined from the average fold change values
from the control and experimental samples. The error associated with these average
ratios was propagated according to the following expression:
σNFC ¼ ðNFCÞ 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σFC
FC
 2
þ σFC controlð Þ
FC controlð Þ
 2
s
ð1Þ
where σNFC, σFC, and σFC(control) are the uncertainties in the normalized fold change,
the peak fold change value, and the peak fold change value of the control sample
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(i.e., 0 μM H2O2), respectively. NFC, FC, and FC (control) are the normalized fold
change value, the peak fold change value, and the peak fold change value of the
control sample, respectively.
For the piperlongumine experiment, the ﬁnal probe fold change values were
determined from the average raw emission ratios at the ﬁnal and initial time points.
The error associated with these average ratios was propagated according to the
following expression:
σFC ¼ FCð Þ 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σR t¼0ð Þ
R t ¼ 0ð Þ
 2
þ σR t¼10ð Þ
R t ¼ 10ð Þ
 2
s
ð2Þ
where σFC, σR(t=0), and σR(t=10) are the uncertainties in the fold change, the raw
emission ratio at 0 h, and the raw emission ratio at 10 h, respectively. FC, R(t= 0),
and R(t= 10) are the fold change value, the raw emission ratio value at 0 h, and the
raw emission ratio value at 10 h, respectively. In order to assess the signiﬁcance of
differences in the probe’s fold-change values in all experiments, a two-tailed
student’s t-test was used at a signiﬁcance level of p= 0.02.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the paper and its supplementary information ﬁles. All
constructs created in this study are available upon request.
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